Approach for in vivo delivery of CRISPR/Cas system: a recent update and future prospect

Cell Mol Life Sci. 2021 Mar;78(6):2683-2708. doi: 10.1007/s00018-020-03725-2. Epub 2021 Jan 3.

Abstract

The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) system provides a groundbreaking genetic technology that allows scientists to modify genes by targeting specific genomic sites. Due to the relative simplicity and versatility of the CRISPR/Cas system, it has been extensively applied in human genetic research as well as in agricultural applications, such as improving crops. Since the gene editing activity of the CRISPR/Cas system largely depends on the efficiency of introducing the system into cells or tissues, an efficient and specific delivery system is critical for applying CRISPR/Cas technology. However, there are still some hurdles remaining for the translatability of CRISPR/Cas system. In this review, we summarized the approaches used for the delivery of the CRISPR/Cas system in mammals, plants, and aquacultures. We further discussed the aspects of delivery that can be improved to elevate the potential for CRISPR/Cas translatability.

Keywords: CRISPR/Cas; Gene delivery; Gene editing; Gene therapy.

Publication types

  • Review

MeSH terms

  • Animals
  • CRISPR-Cas Systems / genetics*
  • Gene Editing / methods*
  • Gene Transfer Techniques
  • Genetic Vectors / genetics
  • Genetic Vectors / metabolism
  • Humans
  • Immunity
  • Lentivirus / genetics
  • Plants, Genetically Modified / genetics
  • Plants, Genetically Modified / metabolism